Inspire Medical Systems, Inc. (INSP) |
| 51.36 -0.4 (-0.77%) 07-13 16:00 |
| Open: | 51.5 |
| High: | 52.13 |
| Low: | 50.85 |
| Volume: | 685,466 |
| Market Cap: | 1,480(M) |
| PE Ratio: | 19.91 |
| Exchange: | New York Stock Exchange |
| Industry: | Medical - Devices |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 61.33 |
| Resistance 1: | 52.51 |
| Pivot price: | 46.73 |
| Support 1: | 44.61 |
| Support 2: | 39.73 |
| 52w High: | 147.03 |
| 52w Low: | 38.91 |
Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers a safe and proven effective treatment for individuals experiencing moderate to severe forms of OSA. Additionally, the company is pioneering a novel, closed-loop technology designed to continuously track a patient's breathing patterns and administer mild stimulation to the hypoglossal nerve, thereby maintaining an open airway. Founded in 2007, Inspire Medical Systems maintains its corporate headquarters in Golden Valley, Minnesota.
| EPS | 4.400 |
| Book Value | 27.510 |
| PEG Ratio | 0.00 |
| Gross Profit | 27.250 |
| Profit Margin (%) | 14.33 |
| Operating Margin (%) | -0.55 |
| Return on Assets (ttm) | 3.9 |
| Return on Equity (ttm) | 18.4 |
Fri, 10 Jul 2026
Inspire Medical Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Inspire Medical Systems, Inc. - INSP - PR Newswire
Fri, 10 Jul 2026
Inspire Medical Systems (INSP) Faces A Fresh Test As Recalls Put Valuation In Focus - Yahoo Finance
Fri, 10 Jul 2026
Price to sales forward of Inspire Medical Systems, Inc. – NYSE:INSP - TradingView
Thu, 09 Jul 2026
2 Reasons INSP is Risky and 1 Stock to Buy Instead - Yahoo Finance
Tue, 07 Jul 2026
Inspire Medical Systems (INSP) Could Be 5% Undervalued After Class II Device Recalls - Sahm
Mon, 06 Jul 2026
Inspire Medical corrects Q2 2026 results date to Aug. 3 - Stock Titan
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |